Artivion, Inc.
Artivion, Inc. (NYSE: AORT) manufactures, processes, and distributes medical devices and implantable human tissues used mainly by cardiac and vascular surgeons to treat patients with aortic disease. Its products include aortic stent grafts for aneurysms and dissections, On-X mechanical heart valves, BioGlue surgical… From the company’s description.
Over the twelve months to Sep 30, 2026, Artivion, Inc. reported revenue of $481.88M, up 14.0% from a year earlier, and a net loss of $17.59M. Its operating margin was 2.3%, and operations generated $14.89M in cash. In fiscal 2025, it reported revenue of $441.33M, up 13.6% from fiscal 2024, and net income of $9.77M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Artivion, Inc. does
In the company’s own words
Artivion, Inc. (NYSE: AORT) manufactures, processes, and distributes medical devices and implantable human tissues used mainly by cardiac and vascular surgeons to treat patients with aortic disease. Its products include aortic stent grafts for aneurysms and dissections, On-X mechanical heart valves, BioGlue surgical adhesive, synthetic vascular grafts, and PhotoFix bovine patches; its preservation services supply cryopreserved human cardiac and vascular tissues for surgical procedures. Artivion reports two segments: Medical Devices, which sells stent grafts, sealants, On-X products, and other devices, and Preservation Services, which preserves implantable human tissues. Its principal brands include E-vita, E-xtra Design Engineering, E-nside, E-tegra, AMDS, NEXUS, On-X, BioGlue, CryoValve, CryoPatch, CryoVein, and CryoArtery. The company’s portfolio includes businesses acquired over time, notably JOTEC in 2017, On-X Life Technologies in 2016, and Ascyrus in 2020. Its website is www.artivion.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- KENNESAW, GA
- Fiscal year end
- December
- CIK
- 784199
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Artivion, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Artivion, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Artivion, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Artivion, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Artivion, Inc.'s last four quarterly filings that the numbers alone won't show?”